Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 214,317 | 161,953 | 141,141 | 141,823 | 326,817 |
| Marketable Securities | 115,082 | 59,566 | 119,390 | 148,526 | N/A |
| TOTAL | $334,519 | $226,270 | $264,966 | $296,417 | $330,675 |
| Non-Current Assets | |||||
| PPE Net | 9,095 | 9,031 | 7,783 | 6,543 | 3,591 |
| Investments And Advances | 21,512 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 27,243 | 27,897 | 28,061 | 28,600 | 31,786 |
| TOTAL | $57,850 | $36,928 | $35,844 | $35,143 | $35,377 |
| Total Assets | $392,369 | $263,198 | $300,810 | $331,560 | $366,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,161 | 4,172 | 5,842 | 4,093 | 3,492 |
| Accrued Expenses | 17,419 | 16,001 | 17,884 | 14,384 | 12,049 |
| Other current liabilities | N/A | N/A | 1,700 | 3,060 | 3,060 |
| TOTAL | $25,757 | $21,120 | $26,849 | $23,551 | $27,658 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,184 | 18,515 | 18,226 | 18,067 | 19,009 |
| TOTAL | $18,184 | $18,515 | $18,226 | $18,067 | $19,009 |
| Total Liabilities | $43,941 | $39,635 | $45,075 | $41,618 | $46,667 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,465 | 70,947 | 69,947 | 69,893 | 65,758 |
| Common Shares | 85 | 71 | 70 | 70 | 66 |
| Retained earnings | -493,877 | -449,801 | -411,214 | -371,596 | -336,534 |
| Other shareholders' equity | 62,213 | 62,326 | 65,726 | 65,667 | 71,400 |
| TOTAL | $348,428 | $223,563 | $255,735 | $289,942 | $319,385 |
| Total Liabilities And Equity | $392,369 | $263,198 | $300,810 | $331,560 | $366,052 |